Paincare Florida

Low-Dose Naltrexone (LDN)

PAIN CONDITION

Treating chronic pain isn’t one-size-fits-all. If your pain, inflammation and discomfort haven’t responded to conventional treatments, low-dose naltrexone (LDN) therapy may offer the hope you’ve been seeking. Originally developed in the 1980s to treat opioid and alcohol dependence at much higher doses, naltrexone has recently gained attention for its unique benefits when used in much smaller doses for chronic pain and inflammatory conditions.[1] This “off-label” use has shown promising results for patients with fibromyalgia, multiple sclerosis, neuropathy, and other hard-to-treat pain syndromes.[2; 3]

How LDN Therapy Works

At standard doses, naltrexone is FDA-approved to treat opioid and alcohol use disorders. [4] It’s an opioid antagonist, meaning it blocks the body’s opioid receptors to prevent the effects of narcotics and help break the cycle of addiction. [5]

In low doses, naltrexone works quite differently. LDN temporarily blocks these receptors just enough to trigger your body’s natural healing response, prompting an increase in endorphin production; the hormones that act as your body’s own “feel-good” and pain-relieving chemicals. [6; 7]

This short-term blockade also helps calm overactive immune cells (microglia), which play a significant role in chronic pain and inflammation. [8; 9] By quieting this inflammatory response, LDN can reduce pain sensitivity, fatigue, and even “brain fog” associated with conditions like fibromyalgia, complex regional pain syndrome (CRPS), irritable bowel syndrome (IBS), and chronic headaches. These conditions are often linked to central sensitization, which means the nervous system becomes overly sensitive and amplifies pain signals. [8; 10]

LDN is usually taken as a small capsule before bedtime—typically 1.5 to 4.5 mg daily—allowing your body to release natural endorphins overnight. [11] It’s not addictive and generally well tolerated, with mild side effects such as vivid dreams or temporary sleep changes that often improve over time. [4]

Conditions Treated with Low-Dose Naltrexone (LDN)

While LDN is not yet FDA-approved for pain management, research shows it has successfully reduced pain and inflammation in patients.[7]

LDN has been used therapeutically off-label to treat chronic pain and autoimmune conditions, including:

  • Fibromyalgia [1]
  • Complex regional pain syndrome (CRPS) [12]
  • Nerve pain (neuropathy or neuropathic pain) [8]
  • Multiple sclerosis (MS) and autoimmune disorders [13]
  • Chronic fatigue syndrome [7]
  • Inflammatory bowel disease [7]
  • Crohn’s disease [7]
  • Hailey-Hailey[a] disease [7]
  • Cancer [7]

Benefits of Low Dose Naltrexone (LDN)

Low-dose naltrexone doesn’t just mask your pain. It works with your body’s natural systems to promote balance and healing. By restoring normal immune and nervous system function, LDN can provide several significant benefits for managing chronic pain.

Here are some of the key benefits:

  • Reduced chronic pain and inflammation through microglial modulation: LDN helps calm overactive microglia, the immune cells in the brain and spinal cord that amplify pain signals, reducing inflammation and easing chronic pain.[6; 8]
  • Improved mood and sleep due to increased endorphin levels: By boosting natural endorphins, LDN helps lift mood, reduce stress, and promote more restful sleep. [1]
  • Low risk of side effects or dependence: LDN is non-addictive and generally well tolerated, with only mild, short-term side effects like vivid dreams or sleep changes. [3; 4]
  • Improved quality of life with consistent use: Many patients experience less pain, better energy, and improved daily function when using LDN under medical supervision. [12]
  • Balanced immune function and reduced autoimmune flares: LDN helps regulate immune activity, easing symptoms in autoimmune conditions like multiple sclerosis and Hashimoto’s thyroiditis. [ 7; 13]
  • Reduced nerve hypersensitivity: LDN may help calm overactive nerve pathways, decreasing burning, tingling, and other nerve pain symptoms seen in conditions like neuropathy or CRPS. [12]

Talk to a Pain Management Specialist About Low-Dose Naltrexone (LDN) Treatment

If you live with chronic pain from fibromyalgia, neuropathy, autoimmune disorders, or other conditions that haven’t improved with standard care, you may be a good candidate for low-dose naltrexone. The best results often come from a multidisciplinary approach that blends LDN therapy with physical rehabilitation, nutrition, and other pain management techniques to support whole-body healing.[5]

Take the next step toward lasting relief. Talk with a pain management specialist experienced with LDN treatment to find out whether this innovative therapy could help enhance your body’s natural healing and allow you to live more comfortably without relying on heavy medications.

Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your physician or qualified healthcare provider with any questions you may have regarding your medical condition or treatment options. Never disregard professional medical advice or delay seeking care because of something you have read here.

Frequently Asked Questions About Low-Dose Naltrexone (LDN)

Can Low Dose Naltrexone (LDN) be combined with physical therapy or other pain treatments?

Low Dose Naltrexone (LDN) may be one part of a broader plan that includes rehabilitation, medication, behavioral strategies, lifestyle changes, or another procedure. Whether treatments should be combined or separated depends on the diagnosis, expected response, medical history, and the need to determine which intervention produced a benefit or side effect. Patients should give every treating clinician an updated list of therapies and avoid adding or stopping treatment independently. Coordinated timing can support recovery while reducing duplicated care or conflicting instructions.

Can Low Dose Naltrexone (LDN) be repeated or continued long term?

Whether Low Dose Naltrexone (LDN) can be repeated or continued depends on what the treatment involves, the benefit achieved, side effects, cumulative risks, and available alternatives. Some treatments are designed as a limited trial, some can be repeated at clinically appropriate intervals, and others are intended as one-time procedures with ongoing follow-up. Patients should ask what result would justify another treatment and whether there is a recommended limit. Continued use should be based on documented improvement in function or quality of life, not routine scheduling alone.

What questions should I ask when comparing Low Dose Naltrexone (LDN) with alternatives?

Ask how Low Dose Naltrexone (LDN) fits the suspected pain source, what level and duration of improvement are realistic, what evidence supports its use for the specific diagnosis, and which risks matter most for your health history. Compare recovery demands, the need for repeat care, cost, and what happens if the treatment is unsuccessful. It is also reasonable to ask about doing nothing immediately or trying a less invasive option first. A useful decision reflects the patient’s goals and preferences as well as technical eligibility.

How should follow-up be planned after starting Low Dose Naltrexone (LDN)?

Follow-up after Low Dose Naltrexone (LDN) should occur at a time when the expected response can be evaluated meaningfully. The care team should explain what changes may occur first, what information to track, which activities or medicines require special instructions, and whom to contact with concerns. Bring a record of symptom relief, function, side effects, and any new medical events to the visit. Earlier contact is appropriate for unexpected severe symptoms, while routine questions can usually be addressed at the planned reassessment.

What should I ask my insurer about coverage for Low Dose Naltrexone (LDN)?

Coverage for Low Dose Naltrexone (LDN) varies by plan, diagnosis, prior treatment requirements, provider network, and whether authorization is needed. Before scheduling, ask the insurer and treating practice about medical-necessity criteria, required records, facility and professional fees, medication or device charges, and expected out-of-pocket costs. An authorization is not always a guarantee of payment, so retain reference numbers and written estimates. If coverage is denied, ask which reason was given and whether additional documentation or an appeal is available.

What should a family member or caregiver know about Low Dose Naltrexone (LDN)?

A caregiver supporting someone receiving Low Dose Naltrexone (LDN) should understand transportation needs, medication instructions, activity restrictions, expected short-term effects, and the symptoms that require a call to the practice or urgent care. The amount of help needed varies widely, so patients should obtain written instructions rather than relying on general advice. A caregiver can also help document changes in function or side effects. Support should encourage safe independence and follow the treating clinician’s guidance rather than substituting for medical assessment.

Which records should I bring when discussing Low Dose Naltrexone (LDN)?

Useful records for a consultation about Low Dose Naltrexone (LDN) may include imaging and reports, procedure or operative notes, medication history, rehabilitation summaries, allergy information, and a list of prior treatments with their results. Device information and relevant laboratory or nerve-test reports may also matter. Organize documents chronologically and identify the current functional problem you want addressed. Complete records help the clinician avoid repeating ineffective care and determine whether the treatment matches the suspected source of pain.

How can I tell whether Low Dose Naltrexone (LDN) is helping?

Before Low Dose Naltrexone (LDN), identify two or three measurable goals such as sleeping longer, walking farther, sitting through work, using less rescue medication, or completing a specific daily task. After treatment, record both symptom changes and functional changes over the timeframe provided by the clinician. Improvement may be immediate, gradual, partial, or temporary depending on the treatment. A structured record is more useful than relying on a single pain score and helps the care team decide whether to continue, modify, or stop the approach.

Resources:

  1. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol [Internet]. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2 Accessed September 30, 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3962576
  2. Hou YNJ, Gubili J. Use of Low-Dose Naltrexone. The ASCO Post [Internet]. Published March 25, 2023. Accessed September 30, 2025. Available from: https://ascopost.com/issues/march-25-2023/use-of-low-dose-naltrexone
  3. White L. Low-Dose Naltrexone: A Future Gold Medalist? American Family Physician [Internet]. Accessed September 30, 2025. Available from: https://www.aafp.org/pubs/afp/afp-community-blog/entry/low-dose-naltrexone-a-future-gold-medalist.html
  4. Bazin T. Can You Use Naltrexone for Pain Management? Very Well Health [Internet]. Updated January 22, 2024. Accessed September 30, 2025. Available from: https://www.verywellhealth.com/naltrexone-for-pain-management-what-can-it-treat-8419927
  5. Hill J. Low Dose Naltrexone for Pain Management Exploring Its Mechanism, Benefits, and Applications Western Region Coordinator Department of Pain Management. Cleveland Clinic Foundation [Internet]. Accessed September 30, 2025. Available from: https://www.clevelandclinicmeded.com/showcase/EKCC138/docs/1430_Hill_Dose.pdf
  6. How Low Dose Naltrexone (LDN) Works. LDN Research Trust [Internet]. Updated 2021. Accessed September 30, 2025. Available from: https://ldnresearchtrust.org/how-low-dose-naltrexone-works
  7. Toljan K, Vrooman B. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. Med Sci (Basel). 2018;6(4):82. Published 2018 Sep 21. doi:10.3390/medsci6040082 Accessed September 30, 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6313374/
  8. Adam Rupp, Erin Young, Andrea L Chadwick, Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review, Pain Medicine, Volume 24, Issue 11, November 2023, Pages 1270–1281, https://doi.org/10.1093/pm/pnad074 Accessed September 30, 2025. Available from: https://academic.oup.com/painmedicine/article/24/11/1270/7193901
  9. Dara P, Farooqui Z, Mwale F, Choe C, van Wijnen AJ, Im HJ. Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases. Biomedicines [Internet]. 2023;11(6):1620. Published 2023 Jun 2. doi:10.3390/biomedicines11061620 September 30, 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10296090/
  10. Giving LDN Your Best Shot. American Fibromyalgia Syndrome Association (AFSA) [Internet]. Published April 9, 2024. Accessed September 30, 2025. Available from: https://www.fibromyalgiafund.org/giving-ldn-your-best-shot/
  11. Pope C. What is low dose naltrexone (LDN)? Drugs.com [Internet]. Updated October 17, 2024. Accessed September 30, 2025. Available from: https://www.drugs.com/medical-answers/low-dose-naltrexone-ldn-3570335
  12. McKenzie-Brown AM, Boorman DW, Ibanez KR, Agwu E, Singh V. Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series. J Pain Res. 2023;16:1993-1998. Published 2023 Jun 14. doi:10.2147/JPR.S389957 Accessed September 30, 2025. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10276990/
  13. Toljan K, Vrooman B. Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization. Medical Sciences. 2018;6(4):82. doi:https://doi.org/10.3390/medsci6040082 Accessed September 30, 2025. Available from: https://www.mdpi.com/2076-3271/6/4/82
Scroll to Top